Romosozumab versus teriparatide for risk of dementia in individuals with osteoporosis: a target trial emulation study
Osteoporosis International · 2026
DOI: 10.1007/s00198-026-08026-1 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Osteoporosis International, 2026. Verfasst von Masaki Hatano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. h-masaki@g.ecc.u-tokyo.ac.jp. Hauptthemen laut MEDLINE: Teriparatide, Dementia, Bone Density Conservation Agents, Osteoporosis. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The University of Tokyo.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. h-masaki@g.ecc.u-tokyo.ac.jp.
- Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Real-World Evidence, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
- Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Förderung
- The University of Tokyo
Zitieren
APA
Hatano, M., Okada, A., Sasabuchi, Y., Kimura, Y., Sato, S., Ishikura, H., Tanaka, T., Saito, T., Tanaka, S., & Yasunaga, H. (2026). Romosozumab versus teriparatide for risk of dementia in individuals with osteoporosis: a target trial emulation study. Osteoporosis International. https://doi.org/10.1007/s00198-026-08026-1
Vancouver
Hatano M, Okada A, Sasabuchi Y, Kimura Y, Sato S, Ishikura H, et al. Romosozumab versus teriparatide for risk of dementia in individuals with osteoporosis: a target trial emulation study. Osteoporosis International. 2026. doi:10.1007/s00198-026-08026-1
BibTeX
@article{Hatano2026,
author = {Hatano, Masaki and Okada, Akira and Sasabuchi, Yusuke and Kimura, Yuya and Sato, So and Ishikura, Hisatoshi and Tanaka, Takeyuki and Saito, Taku and Tanaka, Sakae and Yasunaga, Hideo},
title = {Romosozumab versus teriparatide for risk of dementia in individuals with osteoporosis: a target trial emulation study},
journal = {Osteoporosis International},
year = {2026},
doi = {10.1007/s00198-026-08026-1}
}
EUVIMED